Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cts (CTS) Research & Development (2016 - 2025)

Cts' Research & Development history spans 16 years, with the latest figure at $5.9 million for Q4 2025.

  • For Q4 2025, Research & Development rose 3.21% year-over-year to $5.9 million; the TTM value through Dec 2025 reached $25.3 million, up 8.04%, while the annual FY2025 figure was $25.3 million, 8.04% up from the prior year.
  • Research & Development reached $5.9 million in Q4 2025 per CTS's latest filing, down from $6.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $6.9 million in Q3 2025 to a low of $5.0 million in Q3 2024.
  • Average Research & Development over 5 years is $6.1 million, with a median of $6.2 million recorded in 2022.
  • Peak YoY movement for Research & Development: fell 23.23% in 2021, then skyrocketed 37.17% in 2025.
  • A 5-year view of Research & Development shows it stood at $5.7 million in 2021, then dropped by 4.94% to $5.4 million in 2022, then decreased by 2.13% to $5.3 million in 2023, then rose by 7.18% to $5.7 million in 2024, then rose by 3.21% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for CTS's Research & Development are $5.9 million (Q4 2025), $6.9 million (Q3 2025), and $6.3 million (Q2 2025).